LIBTAYO (cemiplimab-rwlc) injection. FDA Approved

FDA approved Anti-Cancer medicine LIBTAYO (cemiplimab-rwlc) injection is available upon request. To get best retail price of  LIBTAYO (cemiplimab-rwlc) injection in India, For emergency product orders call 8750295029 (Mr. Neeraj Nagpal) or For enquires email info@medvitaz.com For advanced treatments in India, Medvitaz Pharma Solution can even help patient to discuss with Medical oncologist.
Category: .

LIBTAYO (cemiplimab-rwlc) injection, for intravenous use. Initial U.S. Approval: 09/2018

LIBTAYO (cemiplimab-rwlc) injection is a prescription medicine for Skin Cancer treatment.
INDICATIONS AND USAGE
LIBTAYO is a programmed death receptor-1 (PD-1) blocking antibody indicated for the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC who are not candidates for curative surgery or curative radiation.
DOSAGE FORMS & STRENGTHS
Injection: 350 mg/7 mL (50 mg/mL) solution in a single-dose vial.
Manufactured By: Regeneron
Prescribing Information URL: Click Here

HOW TO MAKE AN ENQUIRY FOR LIBTAYO (cemiplimab-rwlc) injection?

FDA approved Anti-Cancer medicine LIBTAYO (cemiplimab-rwlc) injection is available upon request. To get best retail price of  LIBTAYO (cemiplimab-rwlc) injection in India, For emergency product orders call 8750295029 (Mr. Neeraj Nagpal) or For enquires email info@medvitaz.com For advanced treatments in India, Medvitaz Pharma Solution can even help patient to discuss with Medical oncologist.

Cemiplimab, sold under the brand name Libtayo, is a monoclonal antibody medication for the treatment of squamous cell skin cancer. Cemiplimab belongs to a class of drugs that binds to the programmed death receptor-1 (PD-1), blocking the PD-1/PD-L1 pathway.

The most common side effects include fatigue, rash, diarrhea, musculoskeletal pain, and nausea.

In September 2018, it was approved by the U.S. Food and Drug Administration (FDA) for treating people with metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC who are not candidates for curative surgery or curative radiation. It was approved for medical use in the European Union in June 2019. It was approved for medical use in Australia in July 2020.

Cemiplimab is the first FDA approval of a medication specifically for advanced cutaneous squamous cell carcinoma (CSCC).

HOW AND WHERE TO BUY cemiplimab-rwlc injection?

You can order cemiplimab-rwlc injection through Medvitaz Pharma Solutions under Named Patient Program (NPP). Medvitaz provides patients and physicians access to commercially approved medicines that are not available to them in their own country. Medvitaz objectives is to make quality medicines available at affordable prices for patients and physicians. To get best retail price/cost of cemiplimab-rwlc injection in India, Call 8750295029 or Email urgent@medvitaz.com. FDA approved drugs of Australia, Canada, Delhi, EU, India, New Zealand, Singapore, Switzerland, Turkey & USA.

neeraj
Neeraj Nagpal

Head of Operations

 The profound knowledge of more than 20 years in sales and marketing sector, he has been working dedicatedly and contributing to pharmaceuticals industry. He handles all operations over the country.

Contact Our Team

Contact us and we will reply as soon as possible!

    need help?

     MEDVITAZ is an initiative for helping end-users directly to get the right medicines and right medical treatments from the right source.